InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-20.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by LAI GOLDMAN MYLA, Director. Director active across 4 companies, notably West Pharmaceutical Services INC. Aggregated, 8 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €93k. Activity tracked since 12 June 2023. The latest transaction was filed on 6 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
8,073 sharesCommon StockSEC:0001168581-26-000002:0
1,071 shares0Common StockSEC:0001127602-25-013709:0
564 shares0Common StockSEC:0001127602-24-013406:0
20,000 shares@ US$5.00100.0% of flowCommon StockSEC:0001104659-23-070484:0
Canonical exit: 10 Sept 2023 (T+90)
616 sharesCommon StockSEC:0001562180-23-003696:0
632 sharesCommon StockSEC:0001562180-22-004429:0
577 sharesCommon StockSEC:0001562180-21-003309:0
31,085 sharesCommon StockSEC:0001193614-16-000050:0
8 of 8 declarations
About LAI GOLDMAN MYLA
LAI GOLDMAN MYLA is a Director at West Pharmaceutical Services INC, Akoya Biosciences, Inc. and SEQUENOM INC. She has 8 filings in total, and across the 8 sampled filings the reported activity is mainly an attribution, with 92911 EUR of buys and 0 EUR of sells, between 2016-01-06 and 2025-05-08. The largest listed filing is for Akoya Biosciences, Inc. on 2023-06-12 for 92910.99919821888 EUR.
